CYTOSORBENTS CORPORATION Long-Term Debt, Maturity, Year Five
CYTOSORBENTS CORPORATION (CTSO) had Long-Term Debt, Maturity, Year Five of $333.33 thousand as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2019-05-07
- 2019-03-31: Long-Term Debt, Maturity, Year Five $333.33K.
- 2018-12-31: Long-Term Debt, Maturity, Year Five $1.33M.
- 2018-09-30: Long-Term Debt, Maturity, Year Five $2.33M.
- 2018-06-30: Long-Term Debt, Maturity, Year Five $3.33M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2019-03-31 | $333.33K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.33M 10-K · filed 2019-03-07 |
| 2018-09-30 | $2.33M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $3.33M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.00M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |